æ±äº¬å€§åŠãšç§åŠæè¡æ¯èæ©æ§(JST)ã¯9æ13æ¥ãã³ã¬ã©èãæŸåºããã³ã¬ã©ãçºçããåå ãšãªããã³ã¬ã©æ¯çŽ ãã现èå ã«éã°ããçµè·¯ãèŠåºãããã®éæ¬çµè·¯ãæ¯çŽ ææã«å¿ é ã§ããããšãæããã«ãããšå ±åã§çºè¡šãããæ±äº¬å€§åŠåŠé¢è¬åŠç³»ç ç©¶ç§ã®ç°å£å圊ç¹ä»»åææãšæ°äºæŽç±ææãããJST課é¡éæååºç€ç ç©¶ã®äžç°ãšããŠè¡ã£ãŠããç ç©¶ã®ææã«ãããã®ã§ããã®ææã¯ç±³åœç§åŠã¢ã«ãããŒçŽèŠãProceedings of the National Academy of Sciences of the United States of Americaãã®ãªã³ã©ã€ã³éå ±çã§9æ12æ¥ã®é±(ç±³åœæ±éšæé)ã«å ¬éäºå®ã
ã³ã¬ã©ã¯ãã³ã¬ã©è(Vibrio cholerae)ãç åäœãšããæ¿ããæ°Žæ§æ§ã®äžç¢ã䌎ãèŽæ»çãªçµå£çŽ°èæ§ææçã ãå°è žã«å°éããã³ã¬ã©èãæŸåºããã³ã¬ã©æ¯çŽ ã«ãã£ãŠãè žã®è¡šé¢ã«ãã现èã®æ©èœãæãªãããããšã«ãã£ãŠçºçãããã³ã¬ã©ã®ææåã¯å€§å€åŒ·ããéå»ã«å¹ŸåºŠãäžçç倧æµè¡ãåŒãèµ·ãããçŸåšãã³ã³ãŽããã€ããªã©ã§ã¯ã³ã¬ã©ææã«ãã£ãŠå€ãã®äººãæ»äº¡ããŠããã
ã³ã¬ã©æ¯çŽ ã¯1ã€ã®AãµããŠããããšã5ã€ã®BãµããŠãããããæ§æãããã¿ã³ãã¯è³ªæ§ã®æ¯çŽ ã§ãAãµããŠããããADP-ãªãã·ã«åèœãæã€é µçŽ ãã³ã¬ã©æ¯çŽ ã¯è žè¡šé¢ã®äžç®çްèã«åã蟌ãŸãã现èå°åšå®ã®ãŽã«ãžäœãå°èäœãééããªãããæçµçã«ãµã€ããŸã«(现è質ãã现èå å°åšå®ãé€ããéšåã®ããš)ãžéæ¬ãããæ¬¡ãã§3éäœGã¿ã³ãã¯è³ªã®ADP-ãªãã·ã«åãè¡ãããšã§ã3éäœGã¿ã³ãã¯è³ªã®æåžžçãªæŽ»æ§åãåŒãèµ·ããããã®çµæãšããŠãç°ç¶ã¢ããã·ã³äžãªã³é žã(cAMP:cyclic adenosine monophosphate)ã®æ¿åºŠãç°åžžã«äžæãã现èãçµç¹ããé»è§£è³ªãšæ°Žã倧éã«æŒåºããããšã§ãã³ã¬ã©ç¹æã®æ¿ããäžç¢ãèµ·ãããšèããããŠãããããããã©ã®ãããªçްèèãããŽã«ãžäœãžãšéæ¬ãããã®ããäžæã ã£ã(ç»å1)ã
ç ç©¶ã°ã«ãŒãã§ã¯ãã¢ããªã«ãããªã¶ã«ã®çްèãCOS-1现èããç§©åºã ã£ã现èå°åšå®ã®ååžãæã€ãšããç°å£ç¹ä»»åææãã®2007幎ã®çºèŠãå©çšããããšã§(ç»å2)ãã³ã¬ã©æ¯çŽ ã®çްèå 鿬çµè·¯ãæããã«ãããã®éæ¬çµè·¯ãå¶åŸ¡ããååã®åå®ãè¡ãç ç©¶ãè¡ã£ãã
ä»åæããã«ãªã£ãã®ã¯4ç¹ã1ç¹ç®ã¯ãã³ã¬ã©æ¯çŽ ã¯çްèèããåã蟌ãŸããåŸã现èèãžååå(ãªãµã€ã¯ã«)ããçµè·¯ã«é¢ãã现èå°åšå®ããªãµã€ã¯ãªã³ã°ãšã³ããœãŒã ããçµç±ããŠãŽã«ãžäœãžéã°ãããšããããš(ç»å3)ã
现èã现èå€ã®ç©è³ªãåã蟌ãå¶ã¿ãããšã³ããµã€ããŒã·ã¹ããšåŒã³ããã®å¶ã¿ã«ãã£ãŠåã蟌ãŸããç©è³ªãéã°ãã现èå°åšå®ãç·ç§°ããŠããšã³ããœãŒã ããšåŒã¶ããªãµã€ã¯ãªã³ã°ãšã³ããœãŒã ããšã³ããœãŒã ã®äžçš®ã§ããããšã³ããµã€ããŒã·ã¹ã§åã蟌ãŸããç©è³ªã现èèãžåååããéçš(ãªãµã€ã¯ã«)ã§ééãããšã³ããœãŒã ã®ããšã ã
ãããŠ2ç¹ç®ã¯ããªãµã€ã¯ãªã³ã°ãšã³ããœãŒã ã«å±åšããããšãã¯ãã³2ã¿ã³ãã¯è³ªãããã³ã¬ã©æ¯çŽ ã®ãªãµã€ã¯ãªã³ã°ãšã³ããœãŒã ãããŽã«ãžäœãžã®éæ¬ãå¶åŸ¡ããŠããç¹(ç»å4)ããšãã¯ãã³2ã¯çäœå ã®ã»ãšãã©ã®èåšãçµç¹ã«ååšããŠããã现èå ã§ã¯ãŽã«ãžäœè¿çžéšã«ååšããŠããããã ãããã®æ©èœã«ã€ããŠã¯ãããŸã§æªè§£æã ã£ãã
ç¶ããŠ3ç¹ç®ã¯ããªãµã€ã¯ãªã³ã°ãšã³ããœãŒã ã«ã¯ããªã³è質ã®äžçš®ã§ããããã¹ãã¡ããžã«ã»ãªã³ããè±å¯ã«ååšãããšããããš(ç»å5)ã
æåŸã®4ç¹ç®ã¯ããã¹ãã¡ããžã«ã»ãªã³ãšçµåããã¿ã³ãã¯è³ªãLactC2ãã现èå ã§éå°çºçŸããããšã«ãã£ãŠãã³ã¬ã©æ¯çŽ ã®ãŽã«ãžäœãžã®èŒžéãæå¶ãããããšã (ç»å6)ã
ä»åã®ç ç©¶ã«ãã£ãŠããªãµã€ã¯ãªã³ã°ãšã³ããœãŒã ã®çްèå ç©è³ªèŒžéã«ãããæ°ããæ©èœããªãµã€ã¯ãªã³ã°ãšã³ããœãŒã ãããŽã«ãžäœãžã®èŒžéããšããªãµã€ã¯ãªã³ã°ãšã³ããœãŒã ã®éèŠãªæ§æå åã§ãããšãã¯ãã³2ã¿ã³ãã¯è³ªãšãã¹ãã¡ããžã«ã»ãªã³ãæãããšãªã£ãã
ãªãµã€ã¯ãªã³ã°ãšã³ããœãŒã ãã现èèãžã®ç©è³ªèŒžéã¯æ¢ã«ç¥ãããŠãããããŽã«ãžäœãžã®ç©è³ªèŒžéã¯ä»ååããŠçºèŠãããæ©èœã§ãããããã«ãããèµ€ç¢èãæŸåºãããã·ã¬æ¯çŽ ããæ¯çŽ åæ§å€§è žèãæŸåºãããæç±æ§ãšã³ããããã·ã³ããããã®çš®åããåé¢ãããããªã·ã³ããªã©ããµã€ããŸã«ãžèŒžéãããããšã§æ¯æ§ãçºæ®ããã»ãã®æ¯æ§ã¿ã³ãã¯è³ªããªãµã€ã¯ãªã³ã°ãšã³ããœãŒã ãä»ãã茞éçµè·¯ã«ãã£ãŠãµã€ããŸã«ãžéã°ããçŽ°èæ¯æ§ãçºæ®ããŠããå¯èœæ§ãåºãŠãããšããã
ãŸãä»åã®çºèŠã«ãããã³ã¬ã©æ¯çŽ ã®ãµã€ããŸã«ãžã®äŸµå ¥ããªãµã€ã¯ãªã³ã°ãšã³ããœãŒã ã®æ®µéã§é»å®³ããè¬å€éçºãè¡ãããšãå¯èœãšãªã£ããããã«ãæ¯çŽ ã®æã€é µçŽ æŽ»æ§ãé»å®³ããè¬å€ã®éçºã ãã§ã¯ãªããç©è³èŒžéã®èŠç¹ã«ç«èããææ¯çŽ è¬ã®éçºãšããæ°ããæ²»çæŠç¥ãæå±ããã圢ã ã
ãã®ã»ãã«ããªãµã€ã¯ãªã³ã°ãšã³ããœãŒã ãããŽã«ãžäœãžã®ç©è³èŒžéçµè·¯ããæ¯çŽ ã®ããã ãã«çްèã«åãã£ãŠãããšã¯èãã«ããããšããã现èãéåžžæã«ãã®éæ¬çµè·¯ã䜿ã£ãŠèŒžéããŠããã¿ã³ãã¯è³ªãåå®ããããšã§ããªãµã€ã¯ãªã³ã°ãšã³ããœãŒã ã®æ°ããªçްèçç©åŠçæ©èœãæããã«ã§ããå¯èœæ§ãåºãŠãããšããŠããã





